April 12, 2016
Renowned UC San Francisco immunologist Jeffrey Bluestone, PhD, has been named president and CEO of theParker Institute for Cancer Immunotherapy, a national initiative launched with a $250 million grant from The Parker Foundation, a private philanthropic organization established by Silicon Valley entrepreneur Sean Parker.
April 11, 2016
Congratulations to Alan Ashworth, PhD, and Jennifer Grandis, MD
April 6, 2016
Mitchel Berger, MD, and Jeff Bluestone, PhD, have been named to a Blue Ribbon Panel of scientific experts, cancer leaders and patient advocates that will help to guide the National Cancer Moonshot Initiative.
April 1, 2016
Three researchers from the UCSF Helen Diller Family Comprehensive Cancer Center have received the NCI Outstanding Investigator Award in 2015: Thea D. Tlsty, PhD, Frank McCormick, PhD, FRS, DSc (Hon), and Markus Müschen, MD, PhD.
NCI’s Outstanding Investigator Award supports accomplished leaders in cancer research, ...
March 31, 2016
UC San Francisco received more than $560.4 million in highly competitive funding from the National Institutes of Health in 2015 to advance our research across our schools of dentistry, medicine, nursing, pharmacy and the Graduate Division.
March 24, 2016
Eleni Linos, MD, MPH, DrPH, and Stephen Francis, MS, PhD, have been awarded the first UCSF Cancer Center Impact Grants, to pursue high-risk, high-reward research projects that would’ve been unlikely to be funded through conventional mechanisms.
March 17, 2016
UC San Francisco today announced the establishment of the Quantitative Biosciences Institute (QBI). The mission of QBI, located on the UCSF Mission Bay health sciences campus, is to drive forward the application of computation, mathematics, and statistics toward a deeper understanding of complex problems in biology, with the ultimate goal of developing new treatments for disease.
March 17, 2016
Scientists at UC San Francisco have been able to directly observe, for the first time, how invasive cancer cells create a beachhead as they migrate to the lung in a mouse model of metastatic cancer. What they saw was utterly surprising: early “pioneer” cancer cells that lodge in the lung generally die, but first they shed zombie-like particles that move around on their own and get gobbled up by waves of immune cells.
March 7, 2016
The most intractable common form of breast cancer might in most cases be treatable by drugs that target fat metabolism, according to UC San Francisco researchers who discovered the tumors’ frequent dependence on fat as an energy source, and then successfully treated human breast tumors that they transplanted and grew in mice.
March 2, 2016
Vice President Joe Biden and his wife Jill Biden, PhD, visited UC San Francisco on Saturday, February 27, to discuss the administration’s national “Moonshot” initiative to improve cancer outcomes in the next decade.